# Nuclide record chaarted (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/chaarted/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "chaarted", "NCT00309985" ;
  schema:name "CHAARTED (E3805)"@en ;
  schema:description "The first trial to show chemotherapy at the start of hormone therapy prolongs life in metastatic prostate cancer."@en ;
  schema:url <https://nuclide.cc/trials/chaarted/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00309985> ;
  nuclide:status "positive" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mhspc/> ;
  nuclide:drugs <https://nuclide.cc/drugs/docetaxel/> .